Compare VOR & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | AIRS |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 166.3M |
| IPO Year | 2021 | 2021 |
| Metric | VOR | AIRS |
|---|---|---|
| Price | $8.13 | $3.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $70.43 | $3.75 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 11-13-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $157,554,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.62 | $1.53 |
| 52 Week High | $65.80 | $12.00 |
| Indicator | VOR | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 29.79 | 25.73 |
| Support Level | $7.21 | $3.15 |
| Resistance Level | $8.60 | $3.52 |
| Average True Range (ATR) | 0.87 | 0.48 |
| MACD | 0.55 | 0.01 |
| Stochastic Oscillator | 44.80 | 0.40 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.